Immunological Mechanisms Underlying Autoimmune Disorders: Recent Advances and Therapeutic Implications

Year : 2026 | Volume : 16 | Issue : 01 | Page : 21 25
    By

    V. Basil Hans,

  1. Research Professor, Department of Management and Commerce, Srinivas University, Mangalore, Karnataka, India

Abstract

A diverse range of illnesses known as autoimmune disorders are typified by dysregulated immune responses against self-antigens, which result in tissue damage and persistent inflammation. Understanding the genetic, epigenetic, and environmental variables that contribute to autoimmune pathogenesis has advanced significantly during the last ten years. Current disease models have been transformed by new understandings of immunological tolerance mechanisms such as the functions of regulatory T cells, cytokine networks, and the microbiome. Advances in single-cell analysis, proteomics, and genomes have made it possible to identify biomarkers and classify diseases more accurately, which has led to earlier diagnosis and more personalized treatment plans. Furthermore, the creation of cell-based treatments, small-molecule inhibitors, and targeted biologics has enhanced disease management while lowering systemic immunosuppression and its side effects. To improve patient outcomes and quality of life, this review emphasizes new therapeutic methods, summarizes recent advances in autoimmune research, and discusses current issues and potential future paths ahead. Transitioning from generalized immunosuppression, the management of autoimmune conditions now prioritizes personalized medical interventions. By identifies new trends and potential research avenues, this review seeks to present a thorough summary of recent developments in our understanding of autoimmune disorders and the advancements made to maximize the treatment of autoimmune illnesses.

Keywords: Autoimmune illnesses, biomarkers, genetic susceptibility, immune dysregulation, immunological tolerance, precision medicine, targeted immunotherapy

[This article belongs to Research and Reviews : A Journal of Immunology ]

How to cite this article:
V. Basil Hans. Immunological Mechanisms Underlying Autoimmune Disorders: Recent Advances and Therapeutic Implications. Research and Reviews : A Journal of Immunology. 2026; 16(01):21-25.
How to cite this URL:
V. Basil Hans. Immunological Mechanisms Underlying Autoimmune Disorders: Recent Advances and Therapeutic Implications. Research and Reviews : A Journal of Immunology. 2026; 16(01):21-25. Available from: https://journals.stmjournals.com/rrjoi/article=2026/view=240217


References

  1. Anaya JM, Castiblanco J, Arcos-Burgos M. What is next after the genes for autoimmunity? Autoimmun Rev. 2013;12(12):1212–1216.
  2. Parks CG, Miller FW, Pollard KM, Selmi C, Germolec D, Joyce K, et al. Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease. Int J Mol Sci. 2014;15(8):14269–14297.
  3. Ashraf H, Solla P, Sechi LA. Current advancement of immunomodulatory drugs as potential pharmacotherapies for autoimmune-based neurological diseases. Front Neurol. 2022;13:874186.
  4. Smilek DE, St Clair EW. Solving the puzzle of autoimmunity: Critical questions. Arthritis Rheumatol. 2015;67(5):1139–1143.
  5. Sowa M, Hiemann R, Schierack P, Reinhold D, Roggenbuck D, Conrad K. Next-generation autoantibody testing by combination of screening and confirmation—the CytoBead® technology. Clin Chim Acta. 2016;460:79–84.
  6. Choi MY, Fritzler MJ, Martinez-Prat L, Mahler M. The utilization of autoantibodies in approaches to precision health. Autoimmun Rev. 2018;17(7):693–701.
  7. Tanaka Y, Miyagawa I. Dawn of precision medicine in psoriatic arthritis. Int J Mol Sci. 2022;23(11):6076.
  8. Nakayama Y, Kanayama N, Yamamoto N. Current status, issues and future prospects of personalized medicine for each disease. J Pers Med. 2022;12(3):431.
  9. Sirotti S, Generali E, Ceribelli A, Isailovic N, De Santis M, Selmi C. Personalized medicine in rheumatology: The paradigm of serum autoantibodies. Autoimmun Rev. 2017;16(10):1032–1038.
  10. Abdel-Haq N, Kesselman MM, Beckler MD, Ta E. A review of the efficacy of influenza vaccination in autoimmune disease patients. Hum Vaccin Immunother. 2021;17(8):2562–2570.
  11. Blanchard-Rohner G. Vaccination in children with autoimmune disorders treated with various immunosuppressive regimens: A comprehensive review and practical guide. Front Immunol. 2021;12:671807.
  12. Wang B, Chen S, Zheng Q, Liu Y, Xu H. Peptide-based vaccination therapy for rheumatic diseases. Front Immunol. 2020;11:568011.
  13. Agmon-Levin N, Perricone C, Shoenfeld Y. Novel pebbles in the mosaic of autoimmunity. BMC Med. 2013;11:101.
Regular Issue Subscription Book Review
Volume 16
Issue 01
Received 20/01/2026
Accepted 04/02/2026
Published 17/04/2026
Publication Time 87 Days
10

Login


My IP

PlumX Metrics